DR. ALON SERI-LEVY - CEO
Dr. Alon Seri-Levy has headed Sol-Gel since its inception in 1997. Under his leadership, the company has formed collaborations with multibillion dollar US and global corporations, developed and introduced into the market several products that are still being sold, and raised tens of millions of dollars in private placements before going public on NASDAQ. With Alon as CEO, Sol-Gel has established itself as a fully-GMP pharmaceutical company with post-phase III products.
Alon previously established the computer-aided drug design department at Peptor Ltd., and after a brief period dedicated himself to creating Sol-Gel.
Dr. Seri-Levi holds a Ph.D summa cum laude in chemistry from Jerusalem’s Hebrew University, and has completed a postdoctoral fellowship at Oxford University, UK. He has multiple publications and granted patents to his name.